Cited 8 time in
Caveolin-1-dependent and -independent uPAR signaling pathways contribute to ganglioside GT1b induced early apoptosis in A549 lung cancer cells
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Hwang, Jung-Hoo | - |
| dc.contributor.author | Sung, Jung-Suk | - |
| dc.contributor.author | Kim, Jung Min | - |
| dc.contributor.author | Chung, Young-Ho | - |
| dc.contributor.author | Park, Jun Soo | - |
| dc.contributor.author | Lee, Seung-Hoon | - |
| dc.contributor.author | Jang, Ik-Soon | - |
| dc.date.accessioned | 2024-08-08T03:01:49Z | - |
| dc.date.available | 2024-08-08T03:01:49Z | - |
| dc.date.issued | 2014 | - |
| dc.identifier.issn | 2156-6976 | - |
| dc.identifier.issn | 2156-6976 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/16819 | - |
| dc.description.abstract | Urokinase receptor interacts with alpha 5 beta 1-integrin and enhances cancer cell proliferation and metastasis. Activation of alpha 5 beta 1-integrin requires caveolin-1 and is regulated by uPAR, which upregulates persistently the activated ERK necessary for tumor growth. In this study, we show that the ganglioside GT1b induces proapoptotic signaling through two uPAR-ERK signaling pathways in A549 lung cancer cells. GT1b downregulated the expression of alpha 5 beta 1 integrin, caveolin-1, fibronectin, FAK, and ERK, whereas GT1b upregulated the expression of p53 and uPAR, suggesting GT1b mediated depletion of caveolin-1 in uPAR-expressing A549 cells also disrupts uPAR/integrin complexes, resulting in downregulation of fibronectin-alpha 5 beta 1-integrin-ERK signaling. Following p53 siRNA treatment, FAK and ERK expression was recovered, meaning the presence of reentry uPAR-FAK-ERK signaling pathway. These findings reveal that GT1b is involved in both caveolin-1-dependent uPAR-alpha 5 beta 1-integrin-ERK signaling and caveolin-1-independent uPAR-FAK-ERK signaling. These results suggest a novel function of GT1b as a dual regulator of ERK by modulating caveolin-1 and p53. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | E-CENTURY PUBLISHING CORP | - |
| dc.title | Caveolin-1-dependent and -independent uPAR signaling pathways contribute to ganglioside GT1b induced early apoptosis in A549 lung cancer cells | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.scopusid | 2-s2.0-84949507586 | - |
| dc.identifier.wosid | 000346855300016 | - |
| dc.identifier.bibliographicCitation | AMERICAN JOURNAL OF CANCER RESEARCH, v.4, no.6, pp 801 - 810 | - |
| dc.citation.title | AMERICAN JOURNAL OF CANCER RESEARCH | - |
| dc.citation.volume | 4 | - |
| dc.citation.number | 6 | - |
| dc.citation.startPage | 801 | - |
| dc.citation.endPage | 810 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.subject.keywordPlus | PLASMINOGEN-ACTIVATOR RECEPTOR | - |
| dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
| dc.subject.keywordPlus | UROKINASE RECEPTOR | - |
| dc.subject.keywordPlus | P53 | - |
| dc.subject.keywordPlus | ADHESION | - |
| dc.subject.keywordPlus | PROLIFERATION | - |
| dc.subject.keywordPlus | MIGRATION | - |
| dc.subject.keywordPlus | CAVEOLIN | - |
| dc.subject.keywordAuthor | Lung cancer | - |
| dc.subject.keywordAuthor | ganglioside GT1b | - |
| dc.subject.keywordAuthor | uPAR | - |
| dc.subject.keywordAuthor | caveolin-1 | - |
| dc.subject.keywordAuthor | ERK | - |
| dc.subject.keywordAuthor | p53 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
